HIF1A and chronic myelogenous leukemia, BCR-ABL1 positive: Association between Duration of HU Administration Prior to IM Treatment (≥ 12 months), MDA, HIF-1α, P-gp Level and MMR Achievement in Chronic-phase Chronic Myeloid Leukemia